Public Citizen, a research-based advocacy group representing more than 225,000 members and supporters, has petitioned the Food and Drug Administration (FDA) to immediately add black box warnings and other safety information concerning several severe risks...
DTB-Navarre published an assessment report entitled “Dronedarone (Multaq®) for non-permanent atrial fibrillation. Lower efficacy than amiodarone and a questionable safety profile” (2011, No 5). Excerpt (…) “Its safety profile is far from established. An increase in mortality in patients with heart...
By Stephen Hume, Vancouver Sun June 30, 2011 A letter from 24 eminent physicians, researchers, ethicists and medical school professors objects strenuously to a Canadian advertising campaign that the group says promotes the benefits of a testosterone...
Dabigatran (Pradax®), a direct thrombin inhibitor oral anticoagulant, was licensed in Canada in November 2010 for stroke prevention in patients with non-valvular atrial fibrillation. It is being promoted as an alternative to warfarin with the purported...